Unknown PHASE3 INTERVENTIONAL 2-arm NCT01915134

Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma

A Prospective,Randomized,Controlled,Multicenter,Phase III Study of Stage Ⅲ Study of Gemcitabine Plus Cisplatin With or Without Endostatin to the Metastatic Nasopharyngeal Carcinoma

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Conditions Effects of Chemotherapy Stage IVC Nasopharyngeal Carcinoma

Interventions Gemcitabine and cisplatin Recombinant Human Endostatin plus gemcitabine and cisplatin

Updated 5 times since 2017 Last updated: Dec 30, 2014 Started: Aug 31, 2013 Primary completion: Jan 31, 2016 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Effects of Chemotherapy and Stage IVC Nasopharyngeal Carcinoma and is currently ongoing. Second Affiliated Hospital, School of Medicine, Zhejiang University leads this study, which shows 5 recorded versions since 2013 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Aug 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Second Affiliated Hospital, School of Medicine, Zhejiang University
Sir Run Run Shaw Hospital
Zhejiang Cancer Hospital
Zhejiang University

Data source: Zhejiang Cancer Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hangzhou, China